• On March 5, 2026, Waystar announced an expanded collaboration with Google Cloud to integrate Gemini models and data infrastructure more deeply into its AI-powered healthcare revenue cycle platform, aiming to support more autonomous, hyperscale deployment across complex billing and claims workflows.
• This move brings together financial and clinical intelligence from billions of transactions, positioning Waystar to develop new agentic AI use cases across the full patient and claims lifecycle.
• Next, we’ll examine how integrating Google Cloud’s Gemini models into Waystar’s revenue cycle platform could reshape its long-term investment narrative.

Rare earth metals are the new gold rush. Find out which 28 stocks are leading the charge.

Waystar Holding Investment Narrative Recap

To own Waystar, you need to believe AI can become embedded in the healthcare revenue cycle and keep providers on its unified platform. The expanded Google Cloud collaboration directly reinforces that thesis in the near term by deepening Gemini into AltitudeAI, but it does not remove the biggest risk: rising leverage after the Iodine deal if expected efficiencies and cross sell do not show up in earnings.

The most relevant prior announcement is Waystar’s January 2025 launch of AltitudeAI and agentic intelligence, which framed the shift toward an autonomous revenue cycle. The new Google Cloud phase looks like an extension of that effort, potentially accelerating how quickly new AI agents reach real workflows, which matters for turning Waystar’s strong bookings and implementation backlog into realized revenue and, over time, improved profitability.

Yet while this AI push is exciting, investors should also be aware of how higher leverage after the Iodine acquisition could...

Waystar Holding's narrative projects $1.3 billion revenue and $248.3 million earnings by 2028.

Uncover how Waystar Holding's forecasts yield a $37.00 fair value, a 43% upside to its current price.

Exploring Other Perspectives

Before this news, the most optimistic analysts were modeling revenue near US$1.6 billion and earnings of about US$431.0 million by 2029, far above consensus, assuming rapid AI adoption and strong margins. If health systems slow AI rollouts or favor in house or competing tools instead, that upbeat scenario and the newer Google Cloud announcement could both look very different over time, so it is worth comparing several viewpoints before you decide what you believe.

Explore 5 other fair value estimates on Waystar Holding - why the stock might be worth as much as 73% more than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Waystar Holding research is our analysis highlighting 4 key rewards that could impact your investment decision.
• Our free Waystar Holding research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Waystar Holding's overall financial health at a glance.

Ready For A Different Approach?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 19 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• Invest in the nuclear renaissance through our list of 85 elite nuclear energy infrastructure plays powering the global AI revolution.
• Find 46 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.